Rapid HIV tests could end the epidemic by diagnosing in minutes

NCT ID NCT04793750

Completed Diagnosis Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested three rapid, point-of-care HIV tests to see how well they work compared to standard lab tests. Researchers enrolled 224 adults at high risk for HIV in Baltimore. The goal was to see if faster results help more people start treatment or prevention the same day.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cepheid GeneXpert HIV-1 Qual POC HIV VL test, DPP HIV-Syphilis test system, OraQuick
What this could lead to: If these tests work well, they could help diagnose HIV in minutes instead of days, getting people into care or prevention the same day.
What could go wrong: This is a completed study with 224 participants in one city, so results may not apply everywhere. The tests may not be as accurate as lab tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease sexually transmitted disease syphilis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS SYPHILIS

Contacts and locations

Locations

Johns Hopkins Hospital Emergency Department (JHHED)

Baltimore, Maryland, 21287, United States
The Baltimore City Health Department (BCHD) Health and Wellness Center, Sexual Health Clinics

Baltimore, Maryland, 21217, United States
The John G. Bartlett Specialty Practice (JGBSP)

Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.